The study also found that silencing SIRT1 increases epithelial markers and decreases mesenchymal markers (fibronectin and vimentin), suggesting that SIRT1 promotes EMT (epithelial–mesenchymal transition) in glioma cells, facilitating their invasive capabilities [44]. Here, SIRT1 is linked to central nervous system cancer.